SEC Form 4 · accession 0001179110-19-001239
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia Collins
Director
Period of report
Jan 31, 2019
Accepted (ET)
Feb 4, 2019 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 31, 2019 | A | 8,283 | A | — | — | Common Stock | 8,283 | 8,283 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc.
- F2The restricted stock unit award is scheduled to vest in its entirety on the earlier of (i) July 31, 2019, (ii) the appointment by the Board of Directors of Editas Medicine, Inc. (the "Company") of a permanent chief executive officer or (iii) the termination of a consulting agreement entered into by the Reporting Person and the Company (the "Trigger Date"). On the Trigger Date, all shares will be delivered to the Reporting Person.